Adenosine Signaling in Autoimmune Disorders
Open Access
- 22 September 2020
- journal article
- review article
- Published by MDPI AG in Pharmaceuticals
- Vol. 13 (9) , 260
Abstract
The molecular components of the purinergic system (i.e., receptors, metabolizing enzymes and membrane transporters) are widely expressed in the cells of the immune system. Additionally, high concentrations of adenosine are generated from the hydrolysis of ATP in any “danger” condition, when oxygen and energy availability dramatically drops. Therefore, adenosine acts as a retaliatory metabolite to counteract the nucleotide-mediated boost of the immune reaction. Based on this observation, it can be foreseen that the recruitment with selective agonists of the receptors involved in the immunomodulatory effect of adenosine might represent an innovative anti-inflammatory approach with potential exploitation in autoimmune disorders. Quite surprisingly, pro-inflammatory activity exerted by some adenosine receptors has been also identified, thus paving the way for the hypothesis that at least some autoimmune disorders may be caused by a derailment of adenosine signaling. In this review article, we provide a general overview of the roles played by adenosine on immune cells with a specific focus on the development of adenosine-based therapies for autoimmune disorders, as demonstrated by the exciting data from concluded and ongoing clinical trials.Keywords
Funding Information
- Fondazione Italiana Sclerosi Multipla (#2016/R/7)
- Ministero dell’Istruzione, dell’Università e della Ricerca (Department of Excellence grant program)
This publication has 111 references indexed in Scilit:
- Adenosine‐A3 receptors in neutrophil microdomains promote the formation of bacteria‐tethering cytonemesEMBO Reports, 2013
- Regulation of Neutrophil Function by AdenosineArteriosclerosis, Thrombosis, and Vascular Biology, 2012
- Phenotypical and functional alterations of CD8 regulatory T cells in primary biliary cirrhosisJournal of Autoimmunity, 2010
- Effector and Regulatory T-cell Subsets in Autoimmunity and Tissue InflammationScandinavian Journal of Immunology, 2010
- Expression and functional role of adenosine receptors in regulating inflammatory responses in human synoviocytesBritish Journal of Pharmacology, 2010
- Adenosine receptors in regulation of dendritic cell differentiation and functionBlood, 2008
- A2B Adenosine Receptor Gene Deletion Attenuates Murine ColitisGastroenterology, 2008
- Adenosine receptors: therapeutic aspects for inflammatory and immune diseasesNature Reviews Drug Discovery, 2008
- Adenosine receptor activation ameliorates type 1 diabetesThe FASEB Journal, 2007
- Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cellsNature, 2006